Treatment With Second Generation Tyrosine Kinase Inhibitors (2G TKI) Post Imatinib Failure Survey

Clinical trial NCT01188278 · COMPLETED

Trial details

NCT number: NCT01188278
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Study type: OBSERVATIONAL

Leukemia, Myeloid, Chronic-Phase (CML-CP)

Start date: 2010-07-01
Primary completion: 2013-01-01
Enrollment: 173

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.